The Changing Face of U.S. Corporate R&D Investment
圣路易斯联储 · 经济分析 · November 16, 2026 at 5:30 AM ET
KEY TAKEAWAYS
- Research and development (R&D) now makes up a little more than 20% of all U.S. private nonresidential fixed investment, up from about 15% in 2012.
- The share of corporate R&D funded by companies themselves rose from just over 81% in 2011 to 88% in 2023.
- Software and biotech dominate businesses’ R&D spending, both in terms of overall investment and within many R&D-intensive industries.
- AI-related R&D is expanding rapidly, though as of 2023, it accounted for only a modest share of companies’ total R&D spending.
The shape of U.S. private nonresidential fixed investment has changed significantly over the past decade and a half. A shrinking share of companies’ spending has gone toward traditional categories like structures and equipment, while a growing share has flowed into intellectual property products — a category that includes research and development (R&D). R&D is one of the fastest-growing pieces of that pie: As the first figure below shows, R&D has risen from just under 15% of private nonresidential fixed investment in 2012 to a little more than 20% today, with a notable acceleration from 2018 to 2020.
In this blog post, we use microdata from the National Center for Science and Engineering Statistics’ Business Enterprise Research and Development (BERD) Survey — the primary source underlying the U.S. Bureau of Economic Analysis’ R&D investment series — to look at how businesses’ R&D spending has evolved.Because the annual BERD Survey’s format changed over time, we began our analysis with 2011, when its most recent structure was introduced. Specifically, we examine who funds it, which R&D categories are growing fastest, and which industries have driven spending.
Who Funds R&D?
Historically, the federal government, universities and nonprofits have been major funders of R&D through channels like the National Institutes of Health, the National Science Foundation and the Department of Defense. But as the next figure shows, businesses are now footing more of the bill, with their share of total domestic corporate R&D spending rising from just over 81% in 2011 to 88% in 2023. Over the same period, the share of businesses’ R&D spending that was federally funded declined, from about 11% to approximately 4%, while the share funded through other sources — all those not the company itself or the federal government — remained roughly steady at around 7% to 9%.
What Are the Main Categories of Investment? Have They Changed?
Next, we examine the main categories of R&D investment identified in the BERD Survey: software, biotech, nanotech and artificial intelligence (AI). An important detail is that these four categories are not mutually exclusive. Firms classify their own spending, and a company doing R&D on new AI chips, for instance, is free to report that spending under both “AI” and “nanotech.”
Software and biotech are the two largest categories of businesses’ R&D spending, and each has grown its share of overall investment substantially. The following figure shows that software’s share of total domestic R&D spending by businesses climbed from 29% in 2011 to a peak of roughly 43% in 2021, settling at nearly 42% in 2023. Biotech more than doubled its share over the same period, from about 9% to almost 19%, whereas businesses’ R&D spending on nanotech remained relatively consistent. The AI category is newer; BERD began collecting data on it only in 2019, when it stood at about 3% of businesses’ R&D spending. This category grew quickly, reaching 9% of R&D spending by 2023.
The final four figures look at these same categories of corporate R&D investment from the industry side. We began by identifying the 10 industries with the most total R&D spending in 2023, then determined what share of each industry’s R&D budget went to our four R&D categories (software, biotech, nanotech, AI). These 10 industries together accounted for 87.7% of all domestic R&D spending by companies in 2023, so this view captures where the large majority of R&D dollars are focused. Keep in mind that the R&D categories are not mutually exclusive; because a dollar of R&D can be reported under more than one category, the sum of an industry’s four category shares could exceed 100%.
SOURCES FOR THE FOUR FIGURES: Business Enterprise Research and Development Survey and authors’ calculations.
NOTES FOR THE FOUR FIGURES: The 10 industries shown in each figure had the most total R&D investment by businesses in 2023. Companies may report R&D spending under more than one category, so an industry’s shares could equal more than 100% across the four categories.
Each figure isolates one R&D category and ranks the 10 industries we identified by that category’s share of the industry’s own total R&D investment. Information is by far the most software-intensive industry, with more than 86% of its total R&D spending going to that category. Other nonmanufacturing industries and the professional, scientific and technical services industry follow, with a little over 53% and nearly 38%, respectively.
The AI category shows a pattern of R&D investment similar to that of software but at much lower intensity. The information industry, the most AI-intensive, put about 20% of its total R&D spending into that area. Most of the remaining 10 industries we examined fell below 5%. Even in 2023, there was AI-related R&D occurring across a range of industries, including food, machinery and chemicals.
The chemical industry stands out as the most biotech-intensive, with a little under 79% of its total R&D spending taking place within that category. The chemical industry is followed by the professional, scientific and technical services industry (24%) and the food industry (about 12%). Nanotech is the most evenly spread of the four R&D categories, with the computer and electronic products industry (25% of its total R&D spending) and the machinery industry (roughly 21% of its total R&D spending) on top. The rest of the industries we examined spent single-digit shares of their R&D budgets on nanotech.
Conclusion
Taken together, these patterns point to an R&D landscape for businesses that looks quite different from a decade ago. R&D has grown into a larger share of private investment, and it is increasingly being funded by companies themselves rather than by the government. Within companies’ spending, software and biotech dominate. However, newer R&D categories like AI are expanding rapidly, even though they accounted for a modest share of the total. As AI’s share of businesses’ R&D spending continues to climb from its current level, it will be worth watching whether R&D investment in that category will be as concentrated as software’s and biotech’s, or whether it will be more broad-based across sectors.
Note
- Because the annual BERD Survey’s format changed over time, we began our analysis with 2011, when its most recent structure was introduced.